APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

BMS Gets US Approval Of Ozanimod For Relapsing MS, But Launch Delayed

Thu, 03/26/2020 - 2:18pm

Zeposia, one of three Celgene candidates central to last year’s merger with BMS, obtains US FDA approval in relapsing MS...

      Related Stories 

China 'No' For Celgene's Paclitaxel A Major Blow To BeiGene

Thu, 03/26/2020 - 1:53am

After winning a major procurement contract, BeiGene now may need to find an alternative manufacturing site for  Celgene's Abraxane to...

      Related Stories 

Japan Enhertu Nod Another Boost For Daiichi's Oncology Hopes

Wed, 03/25/2020 - 9:29pm

Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another boost to Japanese firm’s strategic plans to...

      Related Stories 

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

Wed, 03/25/2020 - 2:44pm

AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a...

      Related Stories 

BMS Outlines Clinical Trial Disruptions, Reassures Supply Chain Secure

Wed, 03/25/2020 - 2:20pm

The company is the latest big pharma to announce clinical trial delays due to the COVID-19 pandemic and has postponed...

      Related Stories 

CytomX’s Probody T-Cell Platform Produces Astellas Pact

Wed, 03/25/2020 - 10:31am

Astellas of Japan and Cytomx of the US will deploy the latter’s Probody bispecific technology to design therapeutics that remain...

      Related Stories 

AstraZeneca Likes Sound Of Silence's Science

Wed, 03/25/2020 - 9:53am

The UK major is getting access to Silence's small interfering RNA (siRNA) platform while the London-based biotech is getting further...

      Related Stories 

Novartis's Gene Therapy Zolgensma Has Durable Effects At Five Years

Wed, 03/25/2020 - 9:37am

AveXis/Novartis’s one-time AAV9 vector-based intravenous gene therapy for spinal muscular atrophy, Zolgensma, continues to have beneficial effects up to five...

      Related Stories 

Coronavirus Update: BIO Facilitates COVID-19 Collaborations, ASCO Goes Virtual

Wed, 03/25/2020 - 8:28am

BIO hosts summit to support collaborations on coronavirus vaccines and therapeutics, Vir advances COVID-19 antibody candidates, Gilead renounces orphan status...

      Related Stories 

Alembic: Enough Inventory, China API Supplies Heading Back To Normalcy

Tue, 03/24/2020 - 11:48pm

Alembic says it is 'comfortably placed' in terms of inventories and is seeing improving API supplies from China. The only...

      Related Stories 

GTS Alliance Gives Mochida A Cell Therapy Buy-In

Tue, 03/24/2020 - 11:05pm

Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.

      Related Stories 

Finance Watch: Biotech Stocks Down, But Holding Up Better Than Broader Indices

Tue, 03/24/2020 - 2:10pm

Public Company Edition: Benefitting from hope that biopharma interventions will help the coronavirus pandemic, the industry is faring better than...

      Related Stories 

iOnctura Develops Next-Generation PI3K-Delta Inhibitors For Cancer

Tue, 03/24/2020 - 1:07pm

Emerging Company Profile: Switzerland’s iOnctura is working on PI3K-delta inhibitors and autotaxin inhibitors that have potential in solid tumors and...

      Related Stories